Introduction
============

As the leading cause of death in Korea \[[@b1-crt-2018-142]\], cancer has been the country's major public health concern since 1983. Over 210,000 patients were newly diagnosed with cancer in Korea, and one in four deaths is due to cancer \[[@b2-crt-2018-142]\]. Although the cancer registration system in Korea is highly efficient and can provide nationwide cancer statistics within a relatively brief period, a lag time of at least 2 years is required to collect, and analyze of the data on a specific year. For planning and implementation of comprehensive cancer control programs, it is important to assess the number of new cases and deaths that are expected to occur during the current year. In this study, we report the projected cancer incidence and mortality for the year 2018 based on the data from the 1990s through 2016.

Materials and Methods
=====================

The Korean Ministry of Health and Welfare initiated a nationwide, hospital-based cancer registry, the Korea Central Cancer Registry (KCCR), in 1980. The history, objectives, and activities of the KCCR have been documented in detail elsewhere \[[@b3-crt-2018-142]\]. Incidence data from 1999 to 2015 were obtained from the Korea National Cancer Incidence Database. Cancer cases were classified according to the International Classification of Diseases for Oncology, third edition \[[@b4-crt-2018-142]\], and converted according to the International Classification of Diseases, 10th edition (ICD-10) \[[@b5-crt-2018-142]\]. Mortality data from 1993 to 2016 were acquired from Statistics Korea \[[@b1-crt-2018-142]\]. The cause of death was coded and classified according to ICD-10 \[[@b5-crt-2018-142]\].

The cancer sites included in this study were (1) all cancers combined and (2) the 24 common cancers as follows: lip, oral cavity, and pharynx (C00-C14), esophagus (C15), stomach (C16), colon and rectum (C18-C20), liver and intrahepatic bile duct (liver) (C22), gallbladder and other parts of the biliary tract (gallbladder) (C23-C24), pancreas (C25), larynx (C32), lung and bronchus (lung) (C33-C34), breast (C50), cervix uteri (C53), corpus uteri (C54), ovary (C56), prostate (C61), testis (C62), kidney (C64), bladder (C67), brain and central nervous system (C70-C72), thyroid (C73), Hodgkin lymphoma (C81), non-Hodgkin lymphoma (C82-C86, C96), multiple myeloma (C90), leukemia (C91-C95), and other and ill defined.

Population data from 1993 to 2018 were obtained from the resident registration population, reported by Statistics Korea. Data on the mid-year population, as of July 1 of the respective year, were analyzed. For the year 2018, however, we used population data as of December 31, 2017, because mid-2018 resident registration population was not yet available at the time of analysis.

Linear regression models \[[@b6-crt-2018-142]\] were used to assess time trends and projections. Firstly, we first performed a *Joinpoint* regression analysis on the data available to detect the year when significant changes occurred in cancer trends according to sex and cancer site. A *Joinpoint* regression describes changes in data trends by connecting several different line segments on a log scale at "joinpoints." This analysis was performed using the *Joinpoint* software (ver. 4.3.1; <http://surveillance.cancer.gov/joinpoint>) from the Surveillance Research Program of the U.S. National Cancer Institute \[[@b7-crt-2018-142]\]. We chose the number of joinpoint in order to have least four data points between consecutive joinpoints. Secondly, to predict age-specific cancer rates, a linear regression model was fitted to age-specific rates by 5-year age groups against observed years based on observed cancer incidence data of the latest trend. Finally, we multiply the projected age-specific rates by the age-specific population to get the projected cancer cases and deaths of the year 2018.

We summarized the results by using crude rates (CRs) and age-standardized rates (ASRs) of cancer incidence and mortality. ASRs were standardized using the world standard population \[[@b8-crt-2018-142]\] and expressed per 100,000 persons.

Results
=======

1. Incidence
------------

A total of 204,909 new cancer cases are anticipated in 2018 ([Table 1](#t1-crt-2018-142){ref-type="table"}, [Fig. 1](#f1-crt-2018-142){ref-type="fig"}), with more male (n=112,275) than female (n=92,634) of cancer patients expected.

The projected CRs per 100,000 of all sites combined in 2018 are projected to be 433.8 and 359.7 in men and women, respectively ([Table 2](#t2-crt-2018-142){ref-type="table"}). The projected ASRs per 100,000 of all sites combined are 255.1 and 202.7, respectively. In men, the five leading primary sites of cancer are expected to be the lung (CR, 73.8; ASR, 40.8), stomach (CR, 66.1; ASR, 38.3), colon and rectum (CR, 53.1; ASR, 30.4), liver (CR, 43.8; ASR, 25.3), and prostate (CR, 42.1; ASR, 23.4), accounting for 64.2% of all new cancers in 2018.

In women, the five leading primary sites are expected to be the breast (CR, 83.1; ASR, 52.8), colon and rectum (CR, 37.0; ASR, 16.8), stomach (CR, 34.0; ASR, 16.7), thyroid (CR, 31.5; ASR, 25.5), and lung (CR, 29.6; ASR, 13.7), accounting for 59.9% of all new cancers ([Fig. 1](#f1-crt-2018-142){ref-type="fig"}).

The five most common cancer sites expected in 2018 by sex and age group are shown in [Table 3](#t3-crt-2018-142){ref-type="table"}. Leukemia and thyroid cancer are expected to be the most common forms of cancer in both genders for the 0-14 and 15-34 age groups. Stomach cancer is predicted to be the most prevalent in men aged 35-64 years, while lung cancer is expected to be more frequent in men aged 65 and over. Breast cancer is predicted to be the most common cancer in women 35-64 years of age, whereas colorectal cancer is expected to be the most prevalent in women aged 65 and over. These projections indicate that the incidences of stomach, lung, liver, colorectal and prostate cancers will increase gradually with age for men ([Fig. 2](#f2-crt-2018-142){ref-type="fig"}). In women, the age-specific incidence rates of stomach, colorectal, liver, lung and cervical cancers denote a rising trend in these cancers with age; however, the incidence of breast and thyroid cancer in women is expected to level off after 40s.

2. Mortality
------------

It is estimated that 82,155 cancer deaths will occur in Korea during 2018 ([Table 1](#t1-crt-2018-142){ref-type="table"}, [Fig.1](#f1-crt-2018-142){ref-type="fig"}). The projected CRs per 100,000 of all sites combined in 2018 for men and women are projected to be 195.2 and 122.8, respectively, whereas the projected ASRs per 100,000 of all sites combined are expected to be 108.1 and 51.0, respectively ([Table 4](#t4-crt-2018-142){ref-type="table"}). The predicted five leading cancer sites causing mortality in men are predicted to be lung (CR, 54.5; ASR, 29.1), liver (CR, 31.0; ASR, 17.5), colon and rectum (CR, 21.4; ASR, 11.8), stomach (CR, 17.9; ASR, 9.9), and pancreas (CR, 12.7; ASR, 7.1). During the same period, lung cancer (CR, 20.2; ASR, 7.8) is projected to be the leading cancer cause of death in women, followed by the colon and rectum (CR, 14.8; ASR, 5.5), pancreas (CR, 11.9; ASR, 4.7), liver (CR, 11.5; ASR, 4.5), and breast (CR, 10.4; ASR, 5.8).

The predicted age-specific mortality rates of the selected cancers for males and females in 2018 are shown in further detail in [Fig 3](#f3-crt-2018-142){ref-type="fig"}. When examined by age, Korean men and women aged 60 and over are expected to have the highest mortality rates from lung cancer.

Conclusion
==========

A total of 204,909 new cancer cases and 82,155 cancer deaths are expected to occur in Korea during 2018. The lung cancer is predicted to the most common cancer among male, followed by stomach, colorectal, liver, and prostate cancers. Lung, liver, colorectal, stomach, and pancreatic cancers are expected to be the most common causes of cancer deaths among men. In women, the five leading primary sites are expected to be the breast, colorectal, stomach, thyroid, and lung cancers are anticipated to be the most prevalent, while lung, colorectal, pancreatic, liver, and breast cancers are projected to be the most common causes of cancer-related deaths.

Cancer is currently one of the foremost public health concerns in Korea. Although cancer rates are anticipated to decrease somewhat, but burden of most of cancers will continue to grow with the aging of its population. The current projections of cancer incidence and mortality for 2018 represent an important resource for planning and evaluation of cancer-control programs. As the estimates in this study are model-based, these results should be interpreted with caution. Especially, incidence of some cancers, such as stomach, colorectum and thyroid, started to decrease from early 2010s. So recent trends of those cancers contained only five or six data points, therefore their estimates could be unstable.
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###### 

Estimated new cancer cases and deaths by sex during 2018 in Korea

  Site                                                         Estimated new cases   Estimated deaths                              
  ------------------------------------------------------------ --------------------- ------------------ -------- -------- -------- --------
  All sites                                                    204,909               112,275            92,634   82,155   50,525   31,630
  Lip, oral cavity, and pharynx                                3,627                 2,631              996      1,196    875      321
  Esophagus                                                    2,515                 2,297              218      1,365    1,212    153
  Stomach                                                      25,872                17,103             8,769    7,138    4,624    2,514
  Colon and rectum                                             23,271                13,734             9,537    9,371    5,549    3,822
  Liver^[a)](#tfn1-crt-2018-142){ref-type="table-fn"}^         15,058                11,343             3,715    10,977   8,016    2,961
  Gallbladder^[b)](#tfn2-crt-2018-142){ref-type="table-fn"}^   7,327                 3,878              3,449    4,562    2,253    2,309
  Pancreas                                                     7,539                 3,994              3,545    6,362    3,288    3,074
  Larynx                                                       1,070                 1,040              30       299      298      1
  Lung^[c)](#tfn3-crt-2018-142){ref-type="table-fn"}^          26,725                19,107             7,618    19,317   14,108   5,209
  Breast                                                       21,471                82                 21,389   2,709    19       2,690
  Cervix uteri                                                 2,910                 0                  2,910    763      0        763
  Corpus uteri                                                 2,741                 0                  2,741    357      0        357
  Ovary                                                        2,709                 0                  2,709    1,236    0        1,236
  Prostate                                                     10,904                10,904             0        2,176    2,176    0
  Testis                                                       298                   298                0        18       18       0
  Kidney                                                       5,244                 3,610              1,634    1,186    825      361
  Bladder                                                      4,401                 3,533              868      1,563    1,173    390
  Brain and CNS                                                1,824                 970                854      1,320    674      646
  Thyroid                                                      10,129                2,014              8,115    354      101      253
  Hodgkin lymphoma                                             323                   205                118      64       39       25
  Non-Hodgkin lymphoma                                         4,960                 2,867              2,093    1,966    1,142    824
  Multiple myeloma                                             1,843                 991                852      1,102    594      508
  Leukemia                                                     3,534                 2,019              1,515    1,951    1,132    819
  Other and ill defined                                        18,614                9,655              8,959    4,803    2,409    2,394

CNS, central nervous system.

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract,

Includes the lung and bronchus.

###### 

Estimated crude and age-standardized cancer incidences by sex during 2018 in Korea

  Site                                                         Crude incidence rate per 100,000   Age-standardized incidence rate per 100,000^[a)](#tfn4-crt-2018-142){ref-type="table-fn"}^                           
  ------------------------------------------------------------ ---------------------------------- -------------------------------------------------------------------------------------------- ------- ------- ------- -------
  All sites                                                    396.8                              433.8                                                                                        359.7   222.3   255.1   202.7
  Lip, oral cavity, and pharynx                                7.0                                10.2                                                                                         3.9     4.1     6.1     2.3
  Esophagus                                                    4.9                                8.9                                                                                          0.8     2.5     4.9     0.4
  Stomach                                                      50.1                               66.1                                                                                         34.0    26.7    38.3    16.7
  Colon and rectum                                             45.1                               53.1                                                                                         37.0    23.1    30.4    16.8
  Liver^[b)](#tfn5-crt-2018-142){ref-type="table-fn"}^         29.2                               43.8                                                                                         14.4    15.5    25.3    6.6
  Gallbladder^[c)](#tfn6-crt-2018-142){ref-type="table-fn"}^   14.2                               15.0                                                                                         13.4    6.7     8.3     5.5
  Pancreas                                                     14.6                               15.4                                                                                         13.8    7.2     8.7     5.9
  Larynx                                                       2.1                                4.0                                                                                          0.1     1.1     2.2     0.1
  Lung^[d)](#tfn7-crt-2018-142){ref-type="table-fn"}^          51.8                               73.8                                                                                         29.6    25.5    40.8    13.7
  Breast                                                       41.6                               0.3                                                                                          83.1    26.4    0.2     52.8
  Cervix uteri                                                 5.6                                \-                                                                                           11.3    3.6     \-      7.1
  Corpus uteri                                                 5.3                                \-                                                                                           10.6    3.3     \-      6.5
  Ovary                                                        5.2                                \-                                                                                           10.5    3.4     \-      6.7
  Prostate                                                     21.1                               42.1                                                                                         \-      10.5    23.4    \-
  Testis                                                       0.6                                1.2                                                                                          \-      0.6     1.1     \-
  Kidney                                                       10.2                               13.9                                                                                         6.3     5.9     8.5     3.5
  Bladder                                                      8.5                                13.7                                                                                         3.4     4.1     7.6     1.3
  Brain and CNS                                                3.5                                3.7                                                                                          3.3     2.5     2.8     2.3
  Thyroid                                                      19.6                               7.8                                                                                          31.5    15.4    5.9     25.5
  Hodgkin lymphoma                                             0.6                                0.8                                                                                          0.5     0.5     0.7     0.4
  Non-Hodgkin lymphoma                                         9.6                                11.1                                                                                         8.1     6.1     7.5     4.9
  Multiple myeloma                                             3.6                                3.8                                                                                          3.3     1.8     2.2     1.6
  Leukemia                                                     6.8                                7.8                                                                                          5.9     5.4     6.4     4.5
  Other and ill defined                                        36.0                               37.3                                                                                         34.8    20.3    23.4    17.7

CNS, central nervous system.

Age adjusted to the world standard population,

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract,

Includes the lung and bronchus.

###### 

Estimated cancer incidence by age group and sex during 2018 in Korea

  Rank         Age group (yr)                                                                                                                                          
  ------------ ------------------------------------------------------------ ---------------------------- ------------------------------------------------------------- --------------------------------------------------------------------
  **Male**                                                                                                                                                             
   1           Leukemia (5.0)                                               Thyroid (7.9)                Stomach (64.6)                                                Lung^[a)](#tfn8-crt-2018-142){ref-type="table-fn"}^ (433.8)
   2           Non-Hodgkin lymphoma (2.9)                                   Leukemia (3.5)               Liver^[a)](#tfn8-crt-2018-142){ref-type="table-fn"}^ (48.7)   Stomach (287.9)
   3           Brain and CNS (1.5)                                          Non-Hodgkin lymphoma (3.0)   Colon and rectum (45.2)                                       Prostate (266.6)
   4           Liver^[b)](#tfn9-crt-2018-142){ref-type="table-fn"}^ (0.4)   Testis (2.6)                 Lung (43.6)                                                   Colon and rectum (252.9)
   5                                                                        Colon and rectum (2.5)       Prostate (20.2)                                               Liver^[b)](#tfn9-crt-2018-142){ref-type="table-fn"}^ (166.8)
  **Female**                                                                                                                                                           
   1           Leukemia (4.1)                                               Thyroid (34.9)               Breast (141.3)                                                Colon and rectum (147.9)
   2           Non-Hodgkin lymphoma (1.8)                                   Breast (10.8)                Thyroid (41.7)                                                Stomach (119.0)
   3           Brain and CNS (1.6)                                          Cervix uteri (5.4)           Stomach (29.8)                                                Lung^[a)](#tfn8-crt-2018-142){ref-type="table-fn"}^ (116.7)
   4           Ovary (0.8)                                                  Ovary (3.2)                  Colon and rectum (26.1)                                       Breast (85.7)
   5           Thyroid (0.7)                                                Cervix corpus (2.4)          Lung^[a)](#tfn8-crt-2018-142){ref-type="table-fn"}^ (21.7)    Gallbladder^[c)](#tfn10-crt-2018-142){ref-type="table-fn"}^ (63.2)

CNS, central nervous system.

Includes the lung and bronchus,

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract.

###### 

Estimated crude and age-standardized cancer mortality rates by sex during 2018 in Korea

  Site                                                          Crude mortality rate per 100,000   Age-standardized mortality rate per 100,000^[a)](#tfn11-crt-2018-142){ref-type="table-fn"}^                          
  ------------------------------------------------------------- ---------------------------------- --------------------------------------------------------------------------------------------- ------- ------ ------- ------
  All sites                                                     159.1                              195.2                                                                                         122.8   75.0   108.1   51.0
  Lip, oral cavity, and pharynx                                 2.3                                3.4                                                                                           1.2     1.2    1.9     0.5
  Esophagus                                                     2.6                                4.7                                                                                           0.6     1.2    2.5     0.2
  Stomach                                                       13.8                               17.9                                                                                          9.8     6.4    9.9     3.7
  Colon and rectum                                              18.1                               21.4                                                                                          14.8    8.2    11.8    5.5
  Liver^[b)](#tfn12-crt-2018-142){ref-type="table-fn"}^         21.3                               31.0                                                                                          11.5    10.5   17.5    4.5
  Gallbladder^[c)](#tfn13-crt-2018-142){ref-type="table-fn"}^   8.8                                8.7                                                                                           9.0     3.8    4.7     3.1
  Pancreas                                                      12.3                               12.7                                                                                          11.9    5.8    7.1     4.7
  Larynx                                                        0.6                                1.2                                                                                           0.0     0.3    0.6     0.0
  Lung^[d)](#tfn14-crt-2018-142){ref-type="table-fn"}^          37.4                               54.5                                                                                          20.2    16.8   29.1    7.8
  Breast                                                        5.2                                0.1                                                                                           10.4    3.0    0.0     5.8
  Cervix uteri                                                  1.5                                \-                                                                                            3.0     0.8    \-      1.5
  Corpus uteri                                                  0.7                                \-                                                                                            1.4     0.4    \-      0.7
  Ovary                                                         2.4                                \-                                                                                            4.8     1.3    \-      2.4
  Prostate                                                      4.2                                8.4                                                                                           \-      1.7    4.5     \-
  Testis                                                        0.0                                0.1                                                                                           \-      0.0    0.1     \-
  Kidney                                                        2.3                                3.2                                                                                           1.4     1.1    1.8     0.6
  Bladder                                                       3.0                                4.5                                                                                           1.5     1.2    2.5     0.5
  Brain and CNS                                                 2.6                                2.6                                                                                           2.5     1.6    1.8     1.5
  Thyroid                                                       0.7                                0.4                                                                                           1.0     0.3    0.2     0.3
  Hodgkin lymphoma                                              0.1                                0.2                                                                                           0.1     0.1    0.1     0.0
  Non-Hodgkin lymphoma                                          3.8                                4.4                                                                                           3.2     1.8    2.5     1.3
  Multiple myeloma                                              2.1                                2.3                                                                                           2.0     1.0    1.3     0.8
  Leukemia                                                      3.8                                4.4                                                                                           3.2     2.1    2.7     1.6
  Other and ill defined                                         9.3                                9.3                                                                                           9.3     4.6    5.5     3.9

CNS, central nervous system.

Age adjusted to the world standard population,

Includes the liver and intrahepatic bile duct,

Includes the gallbladder and other/unspecified parts of the biliary tract,

Includes the lung and bronchus.
